BBIO 8-K 2026-10-29

BridgeBio Pharma, Inc. (BBIO) 8-K dated 2026-10-29 — accession 0001743881-26-000033. This URL is the filing, not the BBIO hub.

BridgeBio Pharma, Inc. (BBIO) is a biotechnology company listed on US.

BridgeBio Pharma, Inc. filed a 8-K on 2026-10-29. Accession 0001743881-26-000033.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BBIO revenue for 2025-12-31 was $502.1M. Net income was -$732.9M. Revenue was up 126.3% from 2024-12-31 to 2025-12-31. BBIO currently screens at market cap $13.24B.

Not investment advice. The BBIO SEC hub lists recent forms. The stock page is the research view.